lncRNA-disease association prediction based on latent factor model and projection
Bo Wang1, Chao Zhang2, Xiao-Xin Du2
1College of Computer and Control Engineering, Qiqihar University, Qiqihar, 161006, People's Republic of China. drbowang@163.com.
Scientific Reports
|October 8, 2021
Summary
This study introduces LFMP, a novel computational model for predicting long non-coding RNA (lncRNA)-disease associations. LFMP accurately identifies potential lncRNA-disease links, aiding targeted biological experiments and improving disease research.
Area of Science:
- Computational biology
- Genomics
- Bioinformatics
Background:
- Long non-coding RNAs (lncRNAs) play crucial roles in disease development.
- Accurate identification of lncRNA-disease associations is vital for understanding disease mechanisms.
- Computational approaches can enhance the efficiency and accuracy of biological experiments.
Purpose of the Study:
- To develop a novel computational model for predicting lncRNA-disease associations.
- To predict unknown lncRNA-disease associations without requiring direct lncRNA-disease data.
- To improve the accuracy and efficiency of biological experiments in lncRNA research.
Main Methods:
- Proposed a latent factor model and projection-based prediction model (LFMP).
- Utilized lncRNA-miRNA and miRNA-disease association data for prediction.
- Employed a leave-one-out cross-validation (LOOCV) framework for performance evaluation.
Main Results:
- The LFMP model achieved an Area Under the Curve (AUC) of 0.8964 under LOOCV.
- LFMP demonstrated superior performance compared to existing state-of-the-art methods.
- Case studies on lung and colorectal tumors validated LFMP's ability to infer undetected lncRNA-disease associations.
Conclusions:
- LFMP is an effective computational tool for predicting lncRNA-disease associations.
- The model's ability to predict novel associations can guide future experimental validation.
- This approach offers a promising direction for computer-aided disease research.
Related Concept Videos
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Genome-wide Association Studies-GWAS
14.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.7K
Non-LTR Retrotransposons
12.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.1K


